• Keeping It Real: Challenges And Benefits Of Integrating AI And Machine Learning Into Pharma R&D

    Bio-IT World Contributed Commentary | Productivity in the pharmaceutical industry is rapidly declining. This crisis has created a need to re-think the way clinical trials are conceived, designed and conducted. As such, artificial intelligence is poised to transform the industry.

    Jan 3, 2020

  • Illumina, PacBio Terminate Merger Agreement

    Bio-IT World | Illumina and Pacific Biosciences of California today announced that they have mutually agreed to terminate their merger agreement. In accordance with the merger agreement, Illumina will pay Pacific Biosciences a termination fee of $98 million.

    Jan 2, 2020

  • 2020 Bio-IT Predictions: Digital Transformation Creates Opportunity and Obstacles

    Bio-IT World Contributed Commentary | They say change is good, but it’s best if you have the ability to adapt. That’s certainly the case in the IT space, where digital transformation continues to drive rapid advancement across virtually every industry, and certainly in the life sciences. Here are some predictions and potential challenges to consider heading into next year.

    Jan 2, 2020

  • Caris, GenScript, Fuzionaire, and More: News From December 2019

    Bio-IT World | December featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Caris, GenScript, Fuzionaire, and more.

    Dec 23, 2019

  • A Digital Transformation at the City of Hope

    Bio-IT World | City of Hope National Medical Center’s Chief Digital Officer discusses his role at City of Hope, the changing point-of-care landscape, and future digital transformations for the industry.

    Dec 19, 2019

  • A Regulatory View of Personalized Therapeutics

    Bio-IT World | The FDA’s Director of the Center for Biologics Evaluation and Research discusses the obstacles in developing gene therapies, emerging developments in the field, and the regulatory landscape surrounding personalized therapeutics.

    Dec 18, 2019